Goldman Sachs Group Inc Bristol Myers Squibb CO Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Goldman Sachs Group Inc holds 12,710,302 shares of BMY stock, worth $736 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
12,710,302
Previous 15,740,727
19.25%
Holding current value
$736 Million
Previous $654 Million
0.62%
% of portfolio
0.11%
Previous 0.11%
Shares
19 transactions
Others Institutions Holding BMY
# of Institutions
2,532Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.9 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.18 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.38 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.51 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.53 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $123B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...